[HTML][HTML] Optimization versus early Switching in monopolar depression: A comprehensive review of a clinical controversy
R Correa, R Philippi - Rev. Chil. Neuropsiquiatr, 2019 - journalofneuropsychiatry.cl
In the current management of monopolar depression, achieving functional recovery as early
as possible is a challenge that today's clinicians cannot evade, as the delay in symptom …
as possible is a challenge that today's clinicians cannot evade, as the delay in symptom …
The effect of paroxetine, venlafaxine and bupropion administration alone and combined on spatial and aversive memory performance in rats
CE de Souza Menezes, RS McIntyre… - Pharmacological …, 2018 - Elsevier
Background The use of antidepressants in combination is common practice following non-
response to single antidepressant agents. Nevertheless, the scientific literature lacks …
response to single antidepressant agents. Nevertheless, the scientific literature lacks …
The Role of Pkcδ Cells and Expression in the Bed Nucleus of the Stria Terminalis in Stress Responses, Threat Detection, and Anxiety-Like Behaviors
KM Williford - 2023 - search.proquest.com
The bed nucleus of the stria terminalis (BNST) is a critical mediator of stress responses and
anxiety-like behaviors. Neurons expressing protein kinase C delta (BNST (PKCδ)) are an …
anxiety-like behaviors. Neurons expressing protein kinase C delta (BNST (PKCδ)) are an …
[HTML][HTML] Optimización versus “Switch” temprano en depresión monopolar: Revisión comprensiva acerca de una controversia clínica
RC Pulido, RP Malatesta - Revista chilena de neuro-psiquiatría, 2019 - SciELO Chile
Lograr la recuperación funcional lo más tempranamente posible en el tratamiento de una
depresión monopolar es un desafío que los clínicos de hoy no pueden eludir, pues el …
depresión monopolar es un desafío que los clínicos de hoy no pueden eludir, pues el …
[HTML][HTML] 早期改善在抗抑郁药治疗重度抑郁症(MDD) 中的研究进展
袁心崧， 朱笑， 施慎逊 - 复旦学报(医学版), 2019 - jms.fudan.edu.cn
在第2 周未达到早期改善(early improvement) 的重度抑郁症(major depressive disorder, MDD)
患者继续维持原治疗方案只有3% 能达到临床治愈, 但尽管早期改善有较高的阴性预测值 …
患者继续维持原治疗方案只有3% 能达到临床治愈, 但尽管早期改善有较高的阴性预测值 …
The Role of PKCd Cells and Expression in the Bed Nucleus of the Stria Terminalis in Stress Responses, Threat Detection, and Anxiety-Like Behaviors
KM Williford - 2023 - ir.vanderbilt.edu
The bed nucleus of the stria terminalis (BNST) is a critical mediator of stress responses and
anxiety-like behaviors. Neurons expressing protein kinase C delta (BNST (PKCδ)) are an …
anxiety-like behaviors. Neurons expressing protein kinase C delta (BNST (PKCδ)) are an …
CENTRAL NEUROMODULATORS IN IRRITABLE BOWEL SYNDROME. WHY, HOW AND WHEN
I Hanna-Jairala, DA Drossman - … journal of the American College of …, 2022 - journals.lww.com
Irritable bowel syndrome are responsive to treatments using central neuromodulators.
Central neuromodulators work by enhancing the synaptic transmission of 5 …
Central neuromodulators work by enhancing the synaptic transmission of 5 …
Predictors of functional response and remission with desvenlafaxine 50 mg and 100 mg: a pooled analysis of randomized, placebo-controlled studies in patients with …
CN Soares, DB Wajsbrot, M Boucher - CNS spectrums, 2020 - cambridge.org
Objective. The value of early functional improvement at week 2 for predicting subsequent
functional outcomes at week 8 was assessed in a pooled analysis of patients with major …
functional outcomes at week 8 was assessed in a pooled analysis of patients with major …
[HTML][HTML] 抑郁症患者抗抑郁治疗无效后换药方法文献综述
冯新新， 王克勤 - 济宁医学院学报, 2017 - jnyxy.cnjournals.org
初次抗抑郁药治疗后, 约2/3 抑郁患者症状未能得到有效缓解. 另外, 还有部分患者因无法耐受的
副反应, 经济状况以及个人偏好等因素无法继续原药治疗. 因此, 换用抗抑郁药是临床上非常普遍 …
副反应, 经济状况以及个人偏好等因素无法继续原药治疗. 因此, 换用抗抑郁药是临床上非常普遍 …
Melatoninin major depresif bozukluk tedavisinde prognostik değeri/Prognostic value of melatonin in the treatment of major depressive disorder
K NAJAFOVA - 2023 - openaccess.bezmialem.edu.tr
Giriş: Çalışmamızda majör depresif bozukluk (MDB) tanısı almış hastalarda antidepresan
tedavisi başlandıktan 48 saat sonraki plazma melatonin (MLT) düzeyi ile antidepresan …
tedavisi başlandıktan 48 saat sonraki plazma melatonin (MLT) düzeyi ile antidepresan …